Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - COST OF REVENUE
Cost of Revenue OCX - OncoCyte Corporation
1.09 M
LAST VALUE
-61.98%
2 YEAR CAGR
14.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR